• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (4591707)   Today's Articles (1619)   Subscriber (49315)
Number Citation Analysis
1
HIV infection of hepatitis B virus (HBV)-infected hepatocytes increases CXCL10 production and is associated with liver fibrosis in HIV-HBV co-infected individuals. J Virus Erad 2019. [DOI: 10.1016/s2055-6640(20)31061-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]  Open
2
O22 The International Coalition to Eliminate Hepatitis B. J Virus Erad 2017. [DOI: 10.1016/s2055-6640(20)30905-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]  Open
3
The hepatitis B e antigen suppresses IL-1β-mediated NF-κB activation in hepatocytes. J Viral Hepat 2011;18:e499-507. [PMID: 21914069 DOI: 10.1111/j.1365-2893.2011.01484.x] [Citation(s) in RCA: 29] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/12/2022]
4
Viral Hepatitis in Children: Unique Features and Opportunities. Clin Infect Dis 2011. [DOI: 10.1093/cid/cir315] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]  Open
5
Characterization of the innate immune signalling pathways in hepatocyte cell lines. J Viral Hepat 2008;15:888-900. [PMID: 18673429 DOI: 10.1111/j.1365-2893.2008.01001.x] [Citation(s) in RCA: 66] [Impact Index Per Article: 4.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/06/2023]
6
Clinical significance of precore and core promoter mutations in genotype D hepatitis B-related chronic liver disease. J Viral Hepat 2008;15:753-60. [PMID: 18507754 DOI: 10.1111/j.1365-2893.2008.00998.x] [Citation(s) in RCA: 30] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/06/2023]
7
Ustekinumab. DRUG FUTURE 2008. [DOI: 10.1358/dof.2008.033.02.1176459] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
8
Elesclomol. DRUG FUTURE 2008. [DOI: 10.1358/dof.2008.033.04.1192992] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
9
Catumaxomab. DRUG FUTURE 2008. [DOI: 10.1358/dof.2008.033.05.1204087] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
10
The Equity and Access Sub Group: current achievements and future challenges in promoting equity in the health sector in Malawi. Malawi Med J 2007. [DOI: 10.4314/mmj.v18i2.10905] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]  Open
11
Identification and sequence analysis of potyviruses infecting crops in Vietnam. Arch Virol 2007;153:45-60. [PMID: 17906829 DOI: 10.1007/s00705-007-1067-1] [Citation(s) in RCA: 40] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/12/2007] [Accepted: 08/27/2007] [Indexed: 10/22/2022]
12
Telaprevir. DRUG FUTURE 2007. [DOI: 10.1358/dof.2007.032.09.1138229] [Citation(s) in RCA: 36] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
13
Mepolizumab. DRUG FUTURE 2007. [DOI: 10.1358/dof.2007.032.10.1145823] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
14
Istaroxime. DRUG FUTURE 2007. [DOI: 10.1358/dof.2007.032.07.1118134] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
15
Celiac disease. DRUG FUTURE 2007. [DOI: 10.1358/dof.2007.032.09.1142312] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
16
Vernakalant Hydrochloride. DRUG FUTURE 2007. [DOI: 10.1358/dof.2007.032.03.1084809] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
17
Lestaurtinib. DRUG FUTURE 2007. [DOI: 10.1358/dof.2007.032.03.1084137] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
18
Axitinib. DRUG FUTURE 2007. [DOI: 10.1358/dof.2007.032.05.1102211] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
19
Tomopenem. DRUG FUTURE 2007. [DOI: 10.1358/dof.2007.032.01.1070582] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
20
Panobinostat. DRUG FUTURE 2007. [DOI: 10.1358/dof.2007.032.04.1094476] [Citation(s) in RCA: 15] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
21
Teduglutide. DRUG FUTURE 2007. [DOI: 10.1358/dof.2007.032.06.1110566] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
22
Ecallantide. DRUG FUTURE 2007. [DOI: 10.1358/dof.2007.032.07.1119724] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
23
Vicriviroc. DRUG FUTURE 2007. [DOI: 10.1358/dof.2007.032.05.1100315] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
24
Satavaptan. DRUG FUTURE 2007. [DOI: 10.1358/dof.2007.032.01.1068028] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
25
Gabapentin Enacarbil. DRUG FUTURE 2006. [DOI: 10.1358/dof.2006.031.09.1034212] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
26
AZD-6244. DRUG FUTURE 2006. [DOI: 10.1358/dof.2006.031.10.1040269] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
27
CERA. DRUG FUTURE 2006. [DOI: 10.1358/dof.2006.031.07.1011205] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
28
AN-2690. DRUG FUTURE 2006. [DOI: 10.1358/dof.2006.031.08.1016496] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
29
P.123 Characterisation of a mouse monoclonal and rabbit polyclonal antibody against the hepatitis B precore protein. J Clin Virol 2006. [DOI: 10.1016/s1386-6532(06)80303-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
30
Fospropofol disodium. DRUG FUTURE 2006. [DOI: 10.1358/dof.2006.031.10.1038240] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
31
Apricitabine. DRUG FUTURE 2006. [DOI: 10.1358/dof.2006.031.12.1057853] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
32
Elocalcitol. DRUG FUTURE 2006. [DOI: 10.1358/dof.2006.031.12.1060203] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
33
Paliperidone. DRUG FUTURE 2006. [DOI: 10.1358/dof.2006.031.07.1008562] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
34
Velafermin. DRUG FUTURE 2006. [DOI: 10.1358/dof.2006.031.08.1015622] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
35
Impaired insulin signaling and the pathogenesis of Alzheimer's disease. Drugs Today (Barc) 2006;42:785-90. [PMID: 17285151 DOI: 10.1358/dot.2006.42.12.1032059] [Citation(s) in RCA: 17] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
36
Tiacumicin B. DRUG FUTURE 2006. [DOI: 10.1358/dof.2006.031.06.1000709] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
37
Tramiprosate. DRUG FUTURE 2006. [DOI: 10.1358/dof.2006.031.06.1001606] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
38
EDP-420. DRUG FUTURE 2006. [DOI: 10.1358/dof.2006.031.06.997162] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
39
Arformoterol Tartrate. DRUG FUTURE 2006. [DOI: 10.1358/dof.2006.031.11.1047743] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
40
Eltrombopag. DRUG FUTURE 2006. [DOI: 10.1358/dof.2006.031.09.1030939] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
41
Eprodisate Sodium. DRUG FUTURE 2006. [DOI: 10.1358/dof.2006.031.07.1012786] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
PrevPage 1 of 1 1Next
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA